中国组织工程研究 ›› 2010, Vol. 14 ›› Issue (31): 5849-5852.doi: 10.3969/j.issn.1673-8225.2010.31.037

• 器官移植基础实验 basic experiments of organ transplantation • 上一篇    下一篇

Taqman探针定量检测ICOS/ICOSL基因表达的方法

赵  琳,顾国浩,史进方,蒋  敏,陈永井,张光波   

  1. 苏州大学附属一院检验科,江苏省临床免疫学实验室,江苏省苏州市     215006
  • 出版日期:2010-07-30 发布日期:2010-07-30
  • 通讯作者: 史进方,硕士,副主任技师,苏州大学附属一院检验科,江苏省苏州市,215006 szsjf2006@126.com
  • 作者简介:赵琳★,女,1982年生,河南省沁阳市人,汉族,苏州大学在读硕士,主要从事分子生物学和免疫学研究。 2009andzl@163.com

Quantitative detection of ICOS/ICOSL gene expression using Taqman Probe technology

Zhao Lin, Gu Guo-hao, Shi Jin-fang, Jiang Min, Chen Yong-jing, Zhang Guang-bo   

  1. Department of Clinical Laboratory, First Affiliated Hospital of Soochow University, Jiangsu Province Clinical Immunolodgy Laboratory, Suzhou   215006, Jiangsu Province, China
  • Online:2010-07-30 Published:2010-07-30
  • Contact: Shi Jin-fang, Master, Associate chief technician, Department of Clinical Laboratory, First Affiliated Hospital of Soochow University, Jiangsu Province Clinical Immunolodgy Laboratory, Suzhou 215006, Jiangsu Province, China szsjf2006@126.com
  • About author:Zhao Lin★, Studying for master’s degree, Department of Clinical Laboratory, First Affiliated Hospital of Soochow University, Jiangsu Province Clinical Immunolodgy Laboratory, Suzhou 215006, Jiangsu Province, China 2009andzl@163.com

摘要:

背景:近年来可诱导共刺激分子(inducible costimulator, ICOS)/可诱导共刺激分子配体(ICOS Ligand,ICOSL)在抗感染、抗移植反应、抗肿瘤、治疗自身免疫性疾病等多方面领域受到了越来越多的关注。目前对ICOS/ICOSL表达量的研究大多基于分子水平,国内外尚鲜见ICOS/ICOSL mRNA定量检测的报道。
目的:构建ICOS/ICOSL cDNA质粒标准品,建立Taqman探针检测ICOSL/ICOSL基因表达量的方法。
方法:以胃腺癌组织总RNA为模板、Random 9 mers为引物反转录合成cDNA,用该cDNA为模板聚合酶链反应扩增人ICOS/ICOSL基因相应的cDNA目的片段,构建PMD-18-ICOS/ICOSL重组质粒,鉴定测序后,用Taqman探针实时荧光定量聚合酶链反应制作标准曲线。
结果与结论:组织提取的总RNA完整性良好,构建的ICOS/ICOSL质粒测序结果与目的片段一致,质粒的原始浓度为6.10×1013,4.31×1013 copies/mL,倍比稀释后用Taqman探针荧光定量聚合酶链反应检测,在1012~1013 copies/mL线性关系良好(R2=1),提示成功建立了Taqman探针定量检测ICOS/ICOSL基因表达的方法。

关键词: 共信号分子, 可诱导共刺激分子, 配体, mRNA, 实时定量聚合酶链反应

Abstract:

BACKGROUND: The inducible costimulatory molecule (ICOS) / its ligand (ICOSL) become more and more attractive in the field of anti-infection, anti-transplantation reaction, anti-tumor and treatment of autoimmune disease. Current studies focus on molecular level of ICOS/ICOSL gene expression, no study reports quantitative detection of ICOS/ICOSL mRNA expression.
OBJECTIVE: To construct the plasmid standard samples of ICOS/ICOSL cDNA, and to detect the ICOS/ICOSL gene expression by the Taqman Probe technology.
METHODS: The cDNA was synthesized by reverse transcription with Random 9 mers as the primer and total RNA from the gastric adenocarcinoma tissues as the template. The target sequences of human ICOS/ICOSL cDNA were amplified by polymerase chain reaction amplification from the resulting cDNA as mentioned above. The PMD-18-ICOS/ICOSL recombinant plasmids were constructed. Standard curve was made by Taqman Probe fluorescence polymerase chain reaction technology after gene sequencing.
RESULT AND CONCLUSION: The composition of total RNA extracted from the tissues was complete and the sequences of the ICOS/ICOSL plasmid were consistent with the target fragments. The initial concentration of plasmids was 6.10×1013, 4.31×1013 copies/mL. The different diluted concentration of the plasmids had good linear relationship (R2=1) after amplifying by Taqman PCR and the linear range was 1012-1013 copies/mL, suggesting that the method which can quantitatively detect the concentration of ICOS/ICOSL gene by Taqman Probe technology was successfully constructed.

中图分类号: